Literature DB >> 10690258

Serum levels of measles IgG antibody activity in children under 5 years in Dar-es-Salaam, Tanzania.

E F Lyamuya1, M I Matee, P Aaby, F Scheutz.   

Abstract

Measles IgG antibody levels were estimated in sera from 685 Tanzanian children, 374 (54.6%) boys and 311 (45.4%) girls aged 18 months to 5 years, using an enzyme-linked immunosorbent assay (ELISA). The children were screened for HIV-1 and 2 antibodies using ELISA, and reactive sera were confirmed by Western blot. Nutritional status was assessed by anthropometry. Overall measles vaccination coverage was 98.8%. Measles antibody activity was not detected in 41 (6.0%) children, and ten (1.5%) had antibody levels below 200 mIU/ml, the cut-off level considered to be protective. The non-reactive samples were from one unvaccinated child, one child with unknown vaccination status and 39 vaccinated children. Measles IgG antibody levels were higher in girls (3452.1 mIU/ml) than in boys (2928.2 mIU/ml) (p = 0.02). Higher mean levels were found in children with a history of low birthweight (< 2.5 kg) (p = 0.03). There were no significant differences in measles antibody levels with regard to variations in nutritional status. No correlation (r2 = 0.002) was found between antibody levels and time elapsed since vaccination. In a multivariable logistic regression analysis, children who were HIV-seropositive (n = 9) were more likely to have non-protective antibody levels < 200 mIU/ml (OR = 5.85; 95% CI: 1.37-24.93).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10690258     DOI: 10.1080/02724939992509

Source DB:  PubMed          Journal:  Ann Trop Paediatr        ISSN: 0272-4936


  1 in total

1.  Safety and Immunogenicity of Measles Vaccination in HIV-Infected and HIV-Exposed Uninfected Children: A Systematic Review and Meta-Analysis.

Authors:  Eleonora A M L Mutsaerts; Marta C Nunes; Martijn N van Rijswijk; Kerstin Klipstein-Grobusch; Diederick E Grobbee; Shabir A Madhi
Journal:  EClinicalMedicine       Date:  2018-07-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.